Ecuador vs Germany: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Ecuador
76.0%
in 2025
Germany
74.0%
in 2025
Ecuador rank
128th
Germany rank
131st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Ecuador
- Germany
How they compare
Ecuador currently reports 76.0% against 74.0% in Germany, a difference of 2.0%.
The two have swapped places 5 times across 18 shared years of data; in 2008 it was Germany ahead.
Ecuador ranks 128th and Germany ranks 131st of 194 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 76.0% | 76.0% | Germany |
| 2010s | 77.5% | 83.2% | 5.7% | Germany |
| 2020s | 75.0% | 76.5% | 1.5% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Ecuador or Germany?
- Ecuador, at 76.0% against 74.0% in Germany as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Ecuador and Germany?
- 2.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Germany?
- 18 years are reported by both, from 2008 to 2025.
- How do Ecuador and Germany rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Ecuador ranks 128th and Germany ranks 131st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.